Role of genetic polymorphisms in clopidogrel response variability: a systematic review

INTRODUCTION: Clopidogrel is a P2Y(12) inhibitor that has become a mainstay treatment following percutaneous intervention with drug-eluting stent placement to decrease restenosis and its potential complications, including sudden cardiac death and ischaemic strokes in patients with significant vascul...

Descripción completa

Detalles Bibliográficos
Autores principales: Lopez, Jose, Mark, Justin, Duarte, Gustavo J, Shaban, Mohammed, Sosa, Franklin, Mishra, Rishabh, Jain, Swati, Tran, An, Khizar, Asma, Karpel, Daniel, Acosta, Giancarlo, Rodriguez-Guerra, Miguel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2023
Materias:
Coronary Artery Disease
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10649851/
https://www.ncbi.nlm.nih.gov/pubmed/37963685
http://dx.doi.org/10.1136/openhrt-2023-002436

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10649851/
https://www.ncbi.nlm.nih.gov/pubmed/37963685
http://dx.doi.org/10.1136/openhrt-2023-002436

Ejemplares similares